Featured Research

from universities, journals, and other organizations

UCLA/Caltech Scientists Develop New Gene Therapy Approach: Discovery Could Help Treat Aids, Cancer And Genetic Disorders

Date:
December 24, 2002
Source:
University Of California, Los Angeles Health Sciences
Summary:
UCLA and California Institute of Technology researchers have developed a new gene therapy approach that prevents the AIDS virus from entering human cells. The technique offers a potential way to treat HIV patients and could apply to any disease caused by a gene malfunction, including cancer.

UCLA and California Institute of Technology researchers have developed a new gene therapy approach that prevents the AIDS virus from entering human cells. The technique offers a potential way to treat HIV patients and could apply to any disease caused by a gene malfunction, including cancer. The Proceedings of the National Academy of Sciences will report the findings online the week of Dec. 23.

Related Articles


The research team created a new application for a genetic technology called small interfering RNA (siRNA). The synthetically designed siRNAs act as a catalyst to reduce the expression of specific genes and slow the progression of disease.

"Synthetic siRNAs are powerful tools, but scientists have been baffled at how to insert them into the immune system in stable form. You can't just sprinkle them on the cells," explained Dr. Irvin S.Y. Chen, director of the UCLA AIDS Institute.

"Our research is the first to create a delivery system using a vehicle derived from HIV itself," he added. "This system allowed us to introduce the siRNAs into the cell, where they can protect against HIV infection."

Chen collaborated with Dr. David Baltimore, the Nobel Laureate who is president of Caltech and a professor of biology there. Working closely with colleagues Dr. Don Sung An and Dr. Xiao-Feng Qin, the scientists constructed an innovative carrier from a disarmed version of the AIDS virus to deliver siRNAs into human cells. Their goal was to genetically erase a receptor - a protein on the surface of the cell - that HIV requires to spread.

"To penetrate a cell, HIV needs two receptors that operate like doorknobs and allow the virus inside," said Baltimore. "HIV grabs the receptor and forces itself into the cell. If we can knock out one of these receptors, we hoped to prevent HIV from infecting the cell."

One of the two receptors is CD4, which is found on the infection-fighting T-cell essential for proper immune function. However, the other receptor - called CCR5 - also plays a role in immune function but is not necessary for normal body function.

In fact, roughly 1 percent of the Caucasian population is born without it. Large studies have shown that these people are naturally protected from HIV infection.

"People normally have two copies of every gene," said Chen. "When one copy of CCR5 is missing or defective, a person can still be infected with HIV, but their disease will develop more slowly. We hypothesized that knocking out CCR5 would curb progression of the disease."

The UCLA and Caltech teams cultured T-cells from healthy persons' blood and inserted siRNAs into the cells. Then they introduced HIV into the petri dish and incubated the culture for eight days. The experiment was repeated four times for accuracy.

When the teams examined the culture, they saw a 10-fold drop in CCR5 expression. If fact, HIV managed to infect less than 20 percent of the cells. The rest of them were protected.

"Our findings raise the hope that we can use this approach or combine it with drugs to treat HIV in people -- particularly in persons who have not experienced good results with other forms of treatment," noted Baltimore.

Now that scientists can introduce siRNAs into the cell, Chen and Baltimore propose that the technology will become a major therapeutic approach for many diseases in the future.

"We can easily make siRNAs and use the carrier to deliver them into different cell types to turn off a gene malfunction," said Chen. "This technology can be used to treat tumors or any disease in which a scientist wishes to knock out a malfunctioning gene."

The technology also holds implications for treating infectious, autoimmune and immunological diseases. "We can apply siRNAs to prevent a micro-organism from entering the body or appearing in the wrong place at the wrong time," added Baltimore. "We can also shut down excess production of a particular hormone. The possibilities are endless."

The National Institute of Allergy and Infectious Diseases and the Damon Runyon-Walter Winchell Fellowship helped support the research.


Story Source:

The above story is based on materials provided by University Of California, Los Angeles Health Sciences. Note: Materials may be edited for content and length.


Cite This Page:

University Of California, Los Angeles Health Sciences. "UCLA/Caltech Scientists Develop New Gene Therapy Approach: Discovery Could Help Treat Aids, Cancer And Genetic Disorders." ScienceDaily. ScienceDaily, 24 December 2002. <www.sciencedaily.com/releases/2002/12/021224092956.htm>.
University Of California, Los Angeles Health Sciences. (2002, December 24). UCLA/Caltech Scientists Develop New Gene Therapy Approach: Discovery Could Help Treat Aids, Cancer And Genetic Disorders. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2002/12/021224092956.htm
University Of California, Los Angeles Health Sciences. "UCLA/Caltech Scientists Develop New Gene Therapy Approach: Discovery Could Help Treat Aids, Cancer And Genetic Disorders." ScienceDaily. www.sciencedaily.com/releases/2002/12/021224092956.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins